28-Apr-2017 - Daiichi Sankyo will plough ¥15bn ($135m) into three Japanese manufacturing facilities to support its antibody-drug conjugate pipeline.
27-Apr-2017 - Boehringer Ingelheim has broken ground on a €700m stainless steel bioproduction facility set to house 135,000L of mammalian cell culture capacity.
27-Apr-2017 - United BioPharma Inc. (UBP), with government backing, has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu Industrial Park, Taiwan.
27-Apr-2017 - Mab-Venture Biopharma has entered a collaboration to establish an antibody development and production plant in China incorporating Thermo Fisher’s single-use bioreactors and SmartFactory automated technology.
25-Apr-2017 - Hands-on teaching offers drugmakers, vendors and regulators a better understanding of bioprocessing, according to the managing director of a training facility in Leiden, The Netherlands.
24-Apr-2017 - Samsung Bioepis’ Renflexis has become the second biosimilar of rheumatoid arthritis biologic Remicade (infliximab) to be recommended for approval in the US.
18-Apr-2017 - Cobra Biologics has said it will spend £15m ($19m) to increase gene therapy production capacity, citing customer demand and market opportunities.
18-Apr-2017 - Fujifilm has invested around $130m into facilities in the US and UK weeks after launching its biopharma CDMO business.
12-Apr-2017 - ATUM has launched itself into the mammalian cell line development space after being awarded patents for its Leap-In transposase genome technology.
05-Apr-2017 - Process automation should be incorporated early when developing large scale cell therapy manufacturing platforms, according to a lead scientist from the UK Catapult.
04-Apr-2017 - Biopharma-reporter.com is at @Eppendorf_AG 's stem cell community day in Hamburg, Germany. Here is a collection of tweets sent from the conference.
04-Apr-2017 - Cellular Biomedicine Group Inc (CBMG) has expanded its stem cell manufacturing facility in Huishan High Tech Park in Wuxi, China.
31-Mar-2017 - Immuno-oncology antibody and vaccine firm Agenus Inc will close a site in Basel and axe 50 jobs as part of a reorganisation.
31-Mar-2017 - Lonza's biopharma business grew faster than other divisions in 2016 with a drug firm becoming the Swiss life science supplier's biggest customer for the first time since 2013
29-Mar-2017 - The US FDA has approved the first systematic treatment for eczema: Sanofi and Regeneron’ monoclonal antibody Dupixent (dupilumab).
27-Mar-2017 - Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive disadvantage.
24-Mar-2017 - Hitachi Chemical Co. America will increase its presence in the cell therapy development and manufacturing space through the $75m acquisition of Caladrius Biosciences subsidiary PCT.
24-Mar-2017 - Eurofins will expand its UK biopharmaceutical testing offering through a £4m ($5m) facility in Livingston, Scotland.
21-Mar-2017 - GlaxoSmithKline has broken ground on a €162m ($175m) meningococcal B vaccine production plant in Germany.
21-Mar-2017 - The European Commission has rejected PIC/S criticism of a plan to develop GMP for advanced therapies and stressed that separate rules will not mean a lowering of standards.
Monitoring spatial product temperature variation is critical to process development and scale-up in the pharma/bio-pharmaceutical indu...
In May 2016, BioPharma-Reporter conducted its inaugural ‘state of the industry’ survey. The key objective of the poll was to gauge vie...